Pembrolizumab (Keytruda) Injection from Japan
Pembrolizumab (Keytruda) is a human monoclonal antibody targeting PD-1, used for advanced cancer immunotherapy such as Hodgkin lymphoma. It is supplied as an injection in pre-filled syringes for retail sale, qualifying under tariff item 3002.15.00 as an immunological product. This product directly regulates immunological processes via checkpoint inhibition.
Duty Rate — Japan → Canada
0%
Import Tips
• Confirm the pre-filled syringes are in retail packaging with measured doses
• Have the product monograph and clinical documentation ready for CBSA
• Check if a Notice of Compliance is required from Health Canada